526445 — Indrayani Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹556.45m
- IN₹2.20bn
- IN₹1.30bn
Annual cashflow statement for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -109 | 42.3 | 119 | 104 | -61.1 |
| Depreciation | |||||
| Non-Cash Items | 21 | -0.15 | 10.2 | 98.3 | 127 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 89 | -10.9 | -1.15 | -544 | -167 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5.18 | 34.7 | 162 | -304 | -67.4 |
| Capital Expenditures | -3.83 | -0.631 | -239 | -165 | -13.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.8 | 6.49 | -235 | 1.48 | 261 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.63 | 5.86 | -474 | -163 | 247 |
| Financing Cash Flow Items | -19.4 | -18.6 | -127 | 32.3 | -119 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -7.3 | -32.3 | 327 | 442 | -183 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.76 | 8.19 | 15.3 | -24.5 | -2.94 |